Alibaba
BABA
Apple
AAPL
Netflix
NFLX
4
Tesla
TSLA
5
Microsoft
MSFT
US Stock MarketDetailed Quotes
TRAW Traws Pharma
- 2.570
- +0.040+1.58%
Close Mar 27 16:00 ET
- 2.570
- 0.0000.00%
Post 20:01 ET
12.94MMarket Cap-0.02P/E (TTM)
2.690High2.520Low20.70KVolume2.570Open2.530Pre Close53.66KTurnover0.63%Turnover RatioLossP/E (Static)5.03MShares26.21852wk High-6.36P/B8.41MFloat Cap2.02052wk Low--Dividend TTM3.27MShs Float1751062.500Historical High--Div YieldTTM6.71%Amplitude2.020Historical Low2.591Avg Price1Lot Size
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call
Traws Pharma Stock Forum
Former CDC Director Unveils Game-Changing Bird Flu and COVID Treatments at Traws Pharma Event
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If y...
Traws Pharma Antiviral Bird Flu Program, Tivoxavir Marboxil, Shows Positive Data in Non-human Primates
Monday, 24th March at 7:00 am
• Tivoxavir marboxil (TXM), administered as a single dose in non-human primates, significantly reduced lung viremia and prevented weight loss, two key measures of antiviral activity in preclinical bird flu models
• Results build on earlier positive findings of mortality benefit for TXM in ferrets and mice
• FDA briefing documents in p...
Breakthrough: Revolutionary Bird Flu Drug Achieves Perfect Survival Rate in Latest Trial Data
Traws Pharma's Bird Flu Drug Candidate, Tivoxavir Marboxil, Presented at ICAR
Friday, 21st March at 7:00 am
• Poster underscores Tivoxavir Marboxil's potential for the treatment of bird flu, supported by 100% survival in a rodent challenge model, potent suppression of resistant viruses and Phase 1 data
• Full dataset to be highlighted during Investor Call on March 31, 2025 at 10:00 AM ET
NEWTOWN, Pa., March 21, 2025 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (NASDAQ: TR...
stocktitan.net/...
Traws Pharma Announces Completion of Phase I Studies with Tivoxavir Marboxil, a Single Dose Oral Investigational Drug for the Treatment and Prevention of H5N1 Bird Flu
Thursday, 23rd January at 7:00 am
Phase I completed in healthy volunteers with pharmacokinetic data supporting dosing for both therapeutic and further development for bird flu prevention
NEWTOWN, Pa., Jan. 23, 2025 /PRNewswire/ -- Traws Pharma, Inc. (NASDAQ: TRAW) ("Traws Pharma", "Traws" or "the Compan...
Traws Pharma Announces Completion of Phase I Studies With Tivoxavir Marboxil, a Single Dose Oral Investigational Drug for the Treatment and Prevention of H5N1 Bird Flu
No comment yet